| Dr Greg Michael Singer, DO | |
|
269 N 1st Ave, Suite 102, Iowa City, IA 52245-3616 | |
| (319) 688-7777 | |
| (319) 688-7776 |
| Full Name | Dr Greg Michael Singer |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 269 N 1st Ave, Iowa City, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750318499 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 3291 (Iowa) | Primary |
| Entity Name | Banner Urgent Care Arizona Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316349855 PECOS PAC ID: 3678749496 Enrollment ID: O20111228000784 |
News Archive
Despite the rapid rise of Alzheimer's disease - the Alzheimer's Association predicts as many as 7.7 million cases by 2030 - there are no preventative treatments available, few in the pharmaceutical pipeline, and those drugs being developed all share the same two molecular targets.
Difficulties with social contact in adolescents from the general population are associated with later development of psychosis, say researchers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
A recent analysis found that U.S. patients with chronic kidney disease have a high prevalence of uncontrolled hypertension and diabetes, and a low use of statins that has not improved over time and is not concordant with guidelines.
UPM researchers are involved in a European network to develop an endoscopic scanner for early detection of certain types of cancers that have a high mortality rate today.
› Verified 7 days ago
| Entity Name | Banner Urgent Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609229764 PECOS PAC ID: 4284921610 Enrollment ID: O20160928001188 |
News Archive
Despite the rapid rise of Alzheimer's disease - the Alzheimer's Association predicts as many as 7.7 million cases by 2030 - there are no preventative treatments available, few in the pharmaceutical pipeline, and those drugs being developed all share the same two molecular targets.
Difficulties with social contact in adolescents from the general population are associated with later development of psychosis, say researchers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
A recent analysis found that U.S. patients with chronic kidney disease have a high prevalence of uncontrolled hypertension and diabetes, and a low use of statins that has not improved over time and is not concordant with guidelines.
UPM researchers are involved in a European network to develop an endoscopic scanner for early detection of certain types of cancers that have a high mortality rate today.
› Verified 7 days ago
| Entity Name | Yavapai Primary Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346871076 PECOS PAC ID: 6305275504 Enrollment ID: O20200409002754 |
News Archive
Despite the rapid rise of Alzheimer's disease - the Alzheimer's Association predicts as many as 7.7 million cases by 2030 - there are no preventative treatments available, few in the pharmaceutical pipeline, and those drugs being developed all share the same two molecular targets.
Difficulties with social contact in adolescents from the general population are associated with later development of psychosis, say researchers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
A recent analysis found that U.S. patients with chronic kidney disease have a high prevalence of uncontrolled hypertension and diabetes, and a low use of statins that has not improved over time and is not concordant with guidelines.
UPM researchers are involved in a European network to develop an endoscopic scanner for early detection of certain types of cancers that have a high mortality rate today.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Greg Michael Singer, DO Po Box 2027, Iowa City, IA 52244-2027 Ph: (319) 339-3541 | Dr Greg Michael Singer, DO 269 N 1st Ave, Suite 102, Iowa City, IA 52245-3616 Ph: (319) 688-7777 |
News Archive
Despite the rapid rise of Alzheimer's disease - the Alzheimer's Association predicts as many as 7.7 million cases by 2030 - there are no preventative treatments available, few in the pharmaceutical pipeline, and those drugs being developed all share the same two molecular targets.
Difficulties with social contact in adolescents from the general population are associated with later development of psychosis, say researchers.
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced that Roche has disclosed positive top-line results from the first randomized trial assessing trastuzumab emtansine in HER2-positive metastatic breast cancer.
A recent analysis found that U.S. patients with chronic kidney disease have a high prevalence of uncontrolled hypertension and diabetes, and a low use of statins that has not improved over time and is not concordant with guidelines.
UPM researchers are involved in a European network to develop an endoscopic scanner for early detection of certain types of cancers that have a high mortality rate today.
› Verified 7 days ago
Joshua Craig Borwick, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7507 | |
Kaylie Duit, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 | |
Adelaide M Gurwell, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-356-1616 | |
Mr. Nathan Alan Shaw, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7000 | |
Alexander Young-oo Dresden, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 | |
Dr. Maresi Berry-stoelzle, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3640 Middlebury Rd, Iowa City, IA 52245 Phone: 319-384-7000 Fax: 319-467-7400 | |
Michael Maharry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Hawkins Dr, Iowa City, IA 52242 Phone: 319-384-7222 Fax: 319-384-7822 |